If you have a story to tell about being a woman with Parkinson’s – or some information about the impact of the condition on women for us to share with the global Parkinson’s community – please get in touch.
“We still have some way to go”
Women and Parkinson's
Author: Caithlin NgPublished: 5 March 2020
Prep: Cook: Serves:
To mark International Women’s Day, we share the highlights of our Women and Parkinson’s campaign – from accounts of how pregnancy and menopause can affect Parkinson’s symptoms, to a look at the ‘data gap’ in research into gender differences
1. “My medication only works three weeks out of four”
UK campaigner and blogger Omotola Thomas, who was diagnosed at the age of 35, shared the impact menstruation has on her Parkinson’s. By monitoring her Parkinson’s symptoms over a month, Omotola noticed a pattern: her Parkinson’s medication was less effective on the days before and during her period.
Omotola noted the impact this has on her roles as wife and mother, as she experiences heightened emotions beyond what she regards as ‘normal premenstrual syndrome’. “Attending my children’s school events, doing household chores, and sometimes simply being engaged in family life require a lot of effort,” she said.
Nevertheless, being aware of these symptoms has helped her better prepare for them. Omotola believes the issue deserves greater attention: “If women can be equipped early with the information on how Parkinson’s will impact them as women, they’ll be in a much better position to manage it.”
Read Omotola’s story here.
2. “Being pregnant was scary”
Since being diagnosed with Parkinson’s six years ago at the age of 29, UK blogger Ellie Finch Hulme has given birth to two children. With little information about Parkinson’s and pregnancy available, Ellie admitted that her first experience “was quite scary”.
Her medication was reduced to the very lowest dose during the pregnancy, resulting in much worsened symptoms. She was unable to make any milk during pregnancy and advised not to breastfeed after.
Ellie found her second pregnancy much easier, however, and has adapted to parenting young children with Parkinson’s. She said: “It’s nothing that can’t be overcome, personally. I just crack on with things just like anybody else, and I try not to worry because stress and anxiety trigger symptoms.”
Read Ellie’s story here
3. “We need to be having more conversations about menopause”
Heather Kennedy, a US writer and campaigner who was diagnosed aged 41, wrote a candid account about her onset menopause. She discussed the changes she’s noticed as she approaches menopause, including a lower libido, an urge to withdraw emotionally and a growing frequency of night sweats – concerns that were dismissed when raised with her doctor.
“I was unsure if it was a result of my medication or because of the menopause,” Heather said. “All of these things melt into one so it’s hard to tell what’s happening to my body. Most of the time the doctors can’t tell.”
Heather highlighted issues like feelings of insecurity and impulse control disorders and implored women with Parkinson’s to “connect with other women at this time in your life” to combat these problems.
“We need to be having way more conversations about menopause, and particularly about how menopause affects women with Parkinson’s.”
Read Heather’s story here.
4. Breaking down the data gap
Medical research into gender differences is only a “new phenomenon”, according to Italian neurologist Marina Picillo. As part of our Women and Parkinsons series, she explored how recognising the unique experience of men and women with the condition is essential for Parkinson’s research and ensuring better treatment.
Marina focuses particularly on dyskinesia in women, their ‘diagnostic delay’, and psychosocial aspects surrounding the condition – such as the tendency for women to pay less attention to their own health as caregivers. She also wants to investigate problems facing women with young onset Parkinson’s, especially those still considering children.
Summarising the current state of research on women and Parkinson’s, Marina said: “There has been progress, and everything is changing – but we still have some way to go.”
Read about Marina’s story here.
5. “Incompetence, racism and prejudice delayed my diagnosis”
It took Manon Day a decade to be diagnosed with Parkinson’s, which the Canadian Parkinson’s campaigner attributes to “incompetence and prejudice”. While her symptoms started at the age of 17, the neurologists she initially consulted disbelieved her; instead, they stereotyped the young black woman as a drug addict.
“It reached the point where I became very ill and could not walk,” Manon shared. “Racism was the cause of my delayed diagnosis and I felt powerless.”
To tackle the underrepresentation of women and minority ethnics in the Parkinson’s research community, she created a Facebook group called Everything about Parkinson’s Disease three years ago. The group connects patients of all ages and races and is over 9,000 members-strong.
Women and Parkinson’s: Our campaign
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Our campaign shares the little-heard stories of women with the condition to find out how their lives are being affected by a
shocking data gap when it comes to women and Parkinson’s. This is just the start.
- We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
- We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
- We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
Join us – #WomenAndParkinsons.
For more information on women and Parkinson’s please visit the EPDA website.
Share this story
“Incompetence, racism and prejudice delayed my diagnosis”
Manon Day on being a young black woman with Parkinson’sREAD MORE
Emma Lawton on her new “bucket list” project
We spoke to Parkinson’s activist Emma LawtonREAD MORE
When will new Parkinson’s psychosis drug be approved outside of the US?
FDA approves drug to treat hallucinations and delusionsREAD MORE